F-box and leucine-rich repeat protein 12 (FBXL12) is a protein encoded by the FBXL12 gene in humans. It's a member of the F-box protein family, a diverse group of proteins characterized by an approximately 40 amino acid motif, the F-box. This motif is critical for protein-protein interactions, especially in the context of the ubiquitin-proteasome system.
F-box proteins typically function as part of a larger protein complex known as SCF (SKP1-cullin-F-box) ubiquitin ligase complex. The F-box proteins, including FBXL12, are responsible for substrate recognition in this complex. They bind to specific proteins, marking them for degradation by the ubiquitin-proteasome system. This system is a primary mechanism for protein turnover in cells, playing a critical role in various cellular processes, including cell cycle progression, signal transduction, and response to oxidative stress.The leucine-rich repeat (LRR) in FBXL12 is another commonly seen motif in proteins and is known for its role in protein-protein interactions. It may contribute to the specific recognition and binding of substrate proteins by FBXL12.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Another proteasome inhibitor, which might impact the ubiquitin-proteasome system and indirectly affect FBXL12 activity. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
A specific inhibitor of the proteasome, potentially influencing the ubiquitin-proteasome pathway and thereby affecting FBXL12 activity. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $41.00 | ||
A selective proteasome inhibitor, potentially affecting the ubiquitin-proteasome system and indirectly impacting FBXL12 activity. | ||||||
ATM/ATR Kinase Inhibitor Inhibitor | 905973-89-9 | sc-202964 | 5 mg | $106.00 | 8 | |
Inhibits the NEDD8-activating enzyme, affecting neddylation and potentially influencing the ubiquitin-proteasome system, thereby indirectly affecting FBXL12. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Affects lysosomal degradation pathways, which might indirectly influence FBXL12 activity by altering cellular protein degradation processes. | ||||||
Auranofin | 34031-32-8 | sc-202476 sc-202476A sc-202476B | 25 mg 100 mg 2 g | $153.00 $214.00 $4000.00 | 39 | |
Inhibits the proteasome, potentially impacting FBXL12 activity by altering protein degradation dynamics. | ||||||
Oprozomib | 935888-69-0 | sc-477447 | 2.5 mg | $280.00 | ||
A proteasome inhibitor, potentially influencing the ubiquitin-proteasome system and indirectly affecting FBXL12 activity. | ||||||